Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gyre Therapeutics

10.28
+1.7119.95%
Post-market: 10.810.5300+5.16%19:52 EDT
Volume:543.76K
Turnover:5.33M
Market Cap:962.34M
PE:205.60
High:10.37
Open:8.71
Low:8.70
Close:8.57
Loading ...

Stock Track | Gyre Therapeutics Soars 7.12% Pre-Market on Profitability Turn and Revenue Beat

Stock Track
·
Yesterday

Stock Track | Gyre Therapeutics Soars 7.12% as 2024 Results Show Profitability Despite EPS Miss

Stock Track
·
Yesterday

Gyre Therapeutics Reports Breakeven in Q4 as Revenue Increases

MT Newswires Live
·
18 Mar

Gyre Therapeutics reports Q4 EPS 0c vs. ($1.39) last year

TIPRANKS
·
18 Mar

Gyre Therapeutics Q4 EPS $0.00 Up From $(1.39) YoY; Sales $27.87M Up From $27.15M YoY

Benzinga
·
18 Mar

Gyre Therapeutics Inc - Q4 Revenues $27.9 Million

THOMSON REUTERS
·
18 Mar

Gyre Therapeutics Q4 Operating Profit USD 665 Thousand

THOMSON REUTERS
·
18 Mar

Gyre Therapeutics Inc Outlook FY25 REV $118 Mln to $128 Mln

THOMSON REUTERS
·
18 Mar

Press Release: Gyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Dow Jones
·
18 Mar

Noble Capital Initiates Coverage on Gyre Therapeutics With Outperform Rating, $20 Price Target

MT Newswires Live
·
11 Mar

Gyre Therapeutics Inc : Noble Capital Initiates Coverage With Outperform Rating; Target Price $20

THOMSON REUTERS
·
11 Mar

BRIEF-Gyre Therapeutics Appoints Ping Zhang To Board Of Directors

Reuters
·
06 Jan

Gyre Therapeutics appoints Ping Zhang to board of directors

TIPRANKS
·
06 Jan

Gyre Therapeutics Announces the Appointment of Ping Zhang to Board of Directors

THOMSON REUTERS
·
06 Jan

Gyre Therapeutics Inc - Ying Luo Resigns as Chairman of Gyre and Gyre Pharmaceuticals

THOMSON REUTERS
·
06 Jan

Press Release: Gyre Therapeutics Announces the Appointment of Ping Zhang to Board of Directors

Dow Jones
·
06 Jan